Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,058 DKK | +2.77% | -0.15% | -4.32% |
05-21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
05-15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.32% | 18.8B | |
+9.61% | 114B | |
+13.11% | 107B | |
-7.59% | 22.22B | |
-1.57% | 21.28B | |
-5.99% | 17.51B | |
-39.36% | 17.17B | |
+6.61% | 14.14B | |
+34.52% | 12.2B | |
+17.13% | 8.01B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Morgan Stanley Adjusts Price Target on Genmab to $34 From $35, Keeps Underweight Rating